ricerca
avanzata
  • Help & Faq
  • Accedi/Login

Anticancer Drug Development Guide - 9781588292285

Un libro in lingua di Teicher Beverly A. (EDT) Andrews Paul A. (EDT) edito da Springer Verlag, 2004

  • € 136.00
  • Il prezzo è variabile in funzione del cambio della valuta d’origine

This thoroughly updated and expanded second edition of Beverly Teicher's widely used classic survey provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included new material on the use of high throughput screening in industry, on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations, and on nonclinical testing to support both human clinical trials, as well as trials of biologic oncology products. The chapters on phase I, II, and III clinical trials and on novel phase II clinical trial designs for targeted therapies have been significantly updated, along with those on cancer drug development in Europe, working with the NCI, and the FDA's role in cancer drug development and setting requirements for approval.

Informazioni bibliografiche